Yang Je Cho,Kwangsung Kim,Na Gyong Lee,Shin Ae Park
申请号：
US16345699
公开号：
US20190290749A1
申请日:
2017.10.30
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to an immune modulator having a novel structure, and an immunologic adjuvant composition containing the same and, more specifically, to an modulator, which is a lipopolysaccharide (LPS) analog having reduced toxicity, and a use thereof. The immune modulator of the present invention exhibits immune enhancement effects by having excellent innate immunity and ability to induce an adaptive immune response to a specific pathogen, and is very safe by having low toxicity. In addition, a vaccine containing the immune modulator of the present invention contains both an immune modulator and an alum, thereby improving immune enhancement effects compared with when using only the immune modulator.
